N-terminal probrain natriuretic peptide level predictive of mortality in ESRD
This article has no abstract so we have provided the first paragraph of the full text.
N-terminal probrain natriuretic peptide (NT-proBNP) is a well established prognostic marker in patients with heart failure. Given that cardiovascular disease is a major cause of death in people with end-stage renal disease (ESRD), it has been suggested that NT-proBNP measurement might facilitate the identification of patients in this population who are at high risk of cardiovascular events. Now, Madsen et al. have demonstrated that NT-proBNP is prognostic for mortality in maintenance hemodialysis patients.
Full text of this article is available with one of the following:
- Membership of the International Society of Nephrology. If already a member, please login. If not please join the Society now
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please login for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or login above.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
